发明名称 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one and an mtor inhibitor
摘要 602807 Disclosed is the use of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]- 1H-quinolin-2-one (dovitnib) or a tautomer thereof or a mixture thereof, or a pharmaceutically acceptable salt thereof, and at least one mTOR inhibitor in the manufacture of a medicament for the treatment and prevention of a proliferative disease or a mTOR dependent disease.
申请公布号 NZ602807(A) 申请公布日期 2014.02.28
申请号 NZ20110602807 申请日期 2011.04.14
申请人 NOVARTIS AG 发明人 GRAUS-PORTA DIANA;SHI MICHAEL;EVANS DEAN BRENT
分类号 A61K31/00;A61K31/436;A61K31/496;A61P35/00 主分类号 A61K31/00
代理机构 代理人
主权项
地址